BRIDGED RING COMPOUNDS AND THEIR THERAPEUTIC USE AS CNS AGENTS

Abstract: disclosed herein are certain therapeutic substituted heterocyclic bridged ring compounds, including substituted morpholine, thiomorpholine, and piperidine compounds and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as mdma, together with pharmaceutical compositions containing such compounds, and methods of their use to treat mental health disorders and cns disorders.

Inventor(s): Alan Borthwick, Fabrizio Micheli, Alessandra Micoli, Ferruccio Palazzesi, Agostino Cianciulli, Robin Tyacke, David Nutt

CPC Classification: C07D498/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250179089